批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/05/13 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/12/11 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/11/09 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/11/09 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/05/30 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/05/29 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2012/09/07 |
SUPPL-30(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/10/01 |
SUPPL-18(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2007/03/26 |
SUPPL-12(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2006/11/28 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/01/28 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/20 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/02/08 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/09/21 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/08/10 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/04/23 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/10/17 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1999/11/22 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
001 |
6015577 |
2017/01/18 |
|
|
U-302 |
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
活性成分:ASPIRIN; DIPYRIDAMOLE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020884 |
001 |
NDA |
AGGRENOX |
ASPIRIN; DIPYRIDAMOLE |
CAPSULE, EXTENDED RELEASE;ORAL |
25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AB |
1999/11/22
|
BOEHRINGER INGELHEIM |